Otitis media at 6-monthly assessments of Australian First Nations children between ages 12–36 months: Findings from two randomised controlled trials of combined pneumococcal conjugate vaccines-Reference-Cited by-同舟云学术

Otitis media at 6-monthly assessments of Australian First Nations children between ages 12–36 months: Findings from two randomised controlled trials of combined pneumococcal conjugate vaccines

Published:2023-12 Issue: Volume:175 Page:111776
ISSN:0165-5876
Container-title:International Journal of Pediatric Otorhinolaryngology
language:en
Short-container-title:International Journal of Pediatric Otorhinolaryngology

Author:

Leach A.J.,Wilson N.,Arrowsmith B.,Beissbarth J.,Mulholland E.K.,Santosham M.,Torzillo P.J.,McIntyre P.,Smith-Vaughan H.,Skull S.A.,Oguoma V.M.,Chatfield M.,Lehmann D.,Binks M.J.,Licciardi P.V.,Andrews R.,Snelling T.,Krause V.,Carapetis J.,Chang A.B.,Morris P.S.

Funder

National Health and Medical Research Council

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Otorhinolaryngology,General Medicine,Pediatrics, Perinatology and Child Health

Reference21 articles.

1. The impact of hearing impairment on early academic achievement in Aboriginal children living in remote Australia: a data linkage study;Su;BMC Publ. Health,2020

2. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines;Leach;Int. J. Pediatr. Otorhinolaryngol.,2016

3. Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial;Leach;Vaccine X,2021

4. Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials;Leach;Lancet Infect. Dis.,2022

5. Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial;Leach;BMC Pediatr.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules;PLOS Medicine;2024-06-03

2. Hearing loss at 6-monthly assessments from age 12 to 36 months: secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules;2024-03-15